STOCK TITAN

Issuer sells 3,817 shares; Claire Mazumdar reported sales (BCAX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

BCAX filed a Form 144 reporting the planned sale of 3,817 common shares by the issuer through the exercise of stock options for cash on 03/06/2026. The filing also discloses prior sales by Claire Mazumdar: 2,631 shares (03/04/2026) and 1,786 shares (03/05/2026) with dollar amounts listed.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does BCAX's Form 144 report?

The Form 144 reports an issuer transaction: 3,817 common shares sold via exercise of stock options for cash on 03/06/2026. It also lists recent individual sales by Claire Mazumdar on 03/04/2026 and 03/05/2026.

Who sold shares in the BCAX filing and when?

The issuer sold 3,817 shares on 03/06/2026 via option exercise for cash. Claire Mazumdar sold 2,631 shares on 03/04/2026 and 1,786 shares on 03/05/2026, as shown in the filing.

What dollar amounts are shown for Claire Mazumdar's sales?

Claire Mazumdar's 03/04/2026 sale is shown as $49,288.63 and the 03/05/2026 sale as $33,464.10 in the Form 144 excerpt provided.

Was the issuer sale in BCAX a cash or noncash transaction?

The issuer transaction is listed as an exercise of stock options and is described as a cash transaction in the filing dated 03/06/2026.
Bicara Therapeutics

NASDAQ:BCAX

BCAX Rankings

BCAX Latest News

BCAX Latest SEC Filings

BCAX Stock Data

1.01B
51.85M
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON